FDA just approved a new drug for early awakenings, called Intermezzo, a low-dose form of zolpidem, the active ingredient in Ambien and Ambien CR. In addition to the lower doses, ea[...]
A recent article in the New York Times summarized findings from a study done by the University of Pittsburgh in which they improved sleep in two-thirds of participants as compared [...]
